Clinical Trial Update: Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tirofiban (Aggrastat) with or on top of a prasugrel loading dose in patients with ST-segment elevation myocardial infarction; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Aggrastat (tirofiban)
• EFFIENT (prasugrel hydrochloride)

Snippet

Sponsor: Università degli Studi di Ferrara | Conditions: ST Segment Elevation Myocardial Infarction | Phase 3 | Status: COMPLETED